Welcome to our dedicated page for Aditxt SEC filings (Ticker: ADTX), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Aditxt, Inc. filings document the company’s life sciences platform, its common stock capital structure, and material events affecting its operating subsidiaries and public-company status. Recent Form 8-K reports cover the completed acquisition of Ignite Proteomics, related financial statements and pro forma information, senior unsecured promissory notes, at-the-market offering capacity, and Nasdaq listing-compliance matters.
Proxy materials and meeting reports describe board elections, auditor ratification, executive-compensation votes, reverse stock split authority, and other stockholder matters. The filing record also includes disclosures on preferred stock issued in acquisition consideration, equity financing arrangements, governance approvals, and risks associated with maintaining exchange listing standards.
Aditxt, Inc. filed an Amendment No. 1 to a Schedule 13G/A disclosing that Justin Ching-Johnson reports 0 shares of Common Stock, representing 0% ownership of the class. The filing lists the issuer address and CUSIP 007025869.
Aditxt, Inc. reports a Schedule 13G showing Justin Ching-Johnson beneficially owns 80,100 shares of Common Stock. The filing lists 80,100 shares, representing 9.8% of the class, with sole voting and dispositive power. The filing gives the reporting person's address in Nova Scotia and is signed 06/18/2026.
HRT Financial LP, a ten percent owner of Aditxt, Inc. (ADTX), reported an open-market sale of 3,132,480 Class A Shares at $0.013 per share. After this transaction on June 16, 2026, the filing shows HRT Financial LP holding 0 Class A Shares directly.
Jeongho Lee reported beneficial ownership of 66,666 shares of Aditxt, Inc. common stock. The filing states Mr. Lee has sole voting and dispositive power over 66,666 shares, representing 8.2% of the class. The signature date is 06/18/2026.
The filing lists the issuer address as 737 N. Fifth Street, Richmond, Virginia, and the filer address as 415 - 50 Holly Street, Toronto, Ontario.
DRW Securities, LLC, a 10% owner of Aditxt, Inc., sold 126,772 shares of Aditxt common stock in an open-market transaction at $0.0079 per share. After this sale, the filing shows DRW Securities with zero shares of Aditxt common stock reported as directly owned.
Aditxt, Inc. reported an insider transaction by major shareholder HRT Financial LP. On June 15, 2026, HRT Financial LP executed an open-market purchase of 2,114,344 shares of Aditxt common stock at $0.014 per share. Following this transaction, HRT Financial LP directly holds 344,964 shares of Aditxt common stock according to the filing. This activity was disclosed on a Form 4 as a transaction by a ten percent owner.
Aditxt, Inc. insider DRW Securities, LLC filed an initial ownership report on Form 3. The filing shows DRW Securities directly holds 126,772 shares of Aditxt common stock as of the reported date. This is a baseline ownership disclosure rather than a new buy or sell transaction.
Aditxt, Inc. disclosure: Joshua Shinkle reports beneficial ownership of 50,500 common shares, representing 6.19% of the class as stated in the filing. The filing lists sole voting and dispositive power over the 50,500 shares. The certification states the shares were not acquired to influence control.
HRT Financial LP, a ten percent owner of Aditxt, Inc., reported an open-market purchase of 4,252,767 shares of Aditxt common stock. The filing shows a purchase price of $0.016 per share. Following this transaction, HRT Financial LP is reported as directly owning 2,459,308 shares of Aditxt common stock.
Bank of America Corporation and related subsidiaries reported very small indirect trades in Aditxt, Inc. (ADTX) common stock on June 11, 2026. The reporting persons executed an open-market sale of 15 shares at $0.01 per share and several open-market purchases totaling 7 shares at prices between $0.01 and $0.02 per share.
After these trades, Form 4 data show small remaining indirect positions, and no derivative securities. The reporting persons collectively disclaim beneficial ownership of the reported shares except to the extent of any pecuniary interest and state that the filing does not concede greater-than-10% beneficial owner status or group status under the Exchange Act.